RLFTY
Price
$5.00
Change
+$0.68 (+15.74%)
Updated
Dec 17 closing price
TRRI
Price
$0.20
Change
-$0.04 (-16.67%)
Updated
Dec 17 closing price
Ad is loading...

RLFTY vs TRRI

Header iconRLFTY vs TRRI Comparison
Open Charts RLFTY vs TRRIBanner chart's image
RELIEF THERAPEUTICS HLDG AG
Price$5.00
Change+$0.68 (+15.74%)
Volume$442
CapitalizationN/A
Trinity Resources
Price$0.20
Change-$0.04 (-16.67%)
Volume$450
CapitalizationN/A
RLFTY vs TRRI Comparison Chart
Loading...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLFTY vs. TRRI commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLFTY is a Sell and TRRI is a Sell.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (RLFTY: $5.00 vs. TRRI: $0.20)
Brand notoriety: RLFTY and TRRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLFTY: 47% vs. TRRI: 16%
Market capitalization -- RLFTY: $57.6M vs. TRRI: $301.05K
RLFTY [@Biotechnology] is valued at $57.6M. TRRI’s [@Biotechnology] market capitalization is $301.05K. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLFTY’s FA Score shows that 1 FA rating(s) are green whileTRRI’s FA Score has 1 green FA rating(s).

  • RLFTY’s FA Score: 1 green, 4 red.
  • TRRI’s FA Score: 1 green, 4 red.
According to our system of comparison, both RLFTY and TRRI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLFTY’s TA Score shows that 4 TA indicator(s) are bullish while TRRI’s TA Score has 4 bullish TA indicator(s).

  • RLFTY’s TA Score: 4 bullish, 4 bearish.
  • TRRI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRRI is a better buy in the short-term than RLFTY.

Price Growth

RLFTY (@Biotechnology) experienced а +7.53% price change this week, while TRRI (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLFTY($57.6M) has a higher market cap than TRRI($301K). RLFTY YTD gains are higher at: 138.095 vs. TRRI (0.000).
RLFTYTRRIRLFTY / TRRI
Capitalization57.6M301K19,136%
EBITDA-48.16MN/A-
Gain YTD138.0950.000-
P/E RatioN/AN/A-
Revenue8.59MN/A-
Total Cash10.7MN/A-
Total Debt2.42MN/A-
FUNDAMENTALS RATINGS
TRRI: Fundamental Ratings
TRRI
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLFTYTRRI
RSI
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
39%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
48%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
RLFTY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALXO1.840.05
+2.79%
ALX Oncology Holdings
PEN247.550.31
+0.13%
Penumbra
OPEN1.91-0.01
-0.52%
Opendoor Technologies
MTW9.35-0.06
-0.64%
Manitowoc Company (The)
CYTO0.41-0.01
-2.05%
Altamira Therapeutics Ltd

RLFTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTY has been loosely correlated with RLFTF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTY jumps, then RLFTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTY
1D Price
Change %
RLFTY100%
N/A
RLFTF - RLFTY
43%
Loosely correlated
N/A
ORKA - RLFTY
23%
Poorly correlated
-4.94%
PCVX - RLFTY
21%
Poorly correlated
-4.57%
HOTH - RLFTY
21%
Poorly correlated
-3.05%
NERV - RLFTY
21%
Poorly correlated
-4.37%
More

TRRI and

Correlation & Price change

A.I.dvisor tells us that TRRI and TNFA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRRI and TNFA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRRI
1D Price
Change %
TRRI100%
N/A
TNFA - TRRI
27%
Poorly correlated
+17.89%
RLFTF - TRRI
24%
Poorly correlated
N/A
RLFTY - TRRI
22%
Poorly correlated
N/A
PRLD - TRRI
22%
Poorly correlated
+2.18%
SRBCF - TRRI
12%
Poorly correlated
N/A
More